奥沙利铂联合氟尿嘧啶同期调强适形放疗治疗局部晚期鼻咽癌疗效观察

doi:10.3969/j.issn.1671-7171.2017.09.009

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨奥沙利铂联合氟尿嘧啶同期调强适形放疗治疗局部晚期鼻咽癌的临床疗效。【方法】选自本院于2012年5月至2014年5月期间收治的局部晚期鼻咽癌患者82例,依据随机数表法分为观察组与对照组各41例。两组患者均采用三维调强适形放疗。对照组在调强放疗基础上同期采用顺铂化疗,观察组在调强放疗基础上同期采用奥沙利铂联合氟尿嘧啶化疗。两组均以21 d为1个周期,连续2~4个周期。比较两组近期疗效,1年和3年局部复发情况、远处转移情况和生存情况及毒副反应发生情况。【结果】两组近期总有效率均为100.00%,差异无统计学意义(P＞0.05);两组1年局部复发率比较无统计学差异(P＞0.05)。观察组3年局部复发率低于对照组(P＜0.05);两组1年远处转移率比较无统计学差异(P＞0.05);观察组3年远处转移率低于对照组(P＜0.05);两组胃肠反应、肝功能、肾功能及口腔黏膜反应发生率比较差异无显著性(P＞0.05);两组1年生存率比较无统计学差异(P＞0.05);观察组3年生存率高于对照组(P＜0.05)。【结论】奥沙利铂联合氟尿嘧啶同期调强适形放疗对局部晚期鼻咽癌患者疗效显著,可降低局部复发和远处转移,延长生存时间,值得临床推广应用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：有机铂化合物/治疗应用, 氟尿嘧啶/治疗应用, 放射疗法, 调强适形, 鼻咽肿瘤/治疗

Abstract：【Objective】To evaluate the efficacy of oxaliplatin combined with 5-fluorouracil concurrent intensity-modulated radiotherapy (IMRT) for locally advanced nasopharyngeal carcinoma (NPC).【Methods】Eighty-two patients with locally advanced nasopharyngeal carcinoma who were treated in our hospital from May 2012 to May 2014 were randomly divided into observation group (41 cases) and control group (41 cases). The two groups of patients were treated with three-dimensional conformal intensity-modulated radiation therapy(IMRT). The control group was treated with cisplatin on the basis of IMRT. The observation group received oxaliplatin combined with 5-fluorouracil on the basis of IMRT. The two groups were treated 21 d for 1 cycle, continuous 2~4 cycles. The short-term efficacy of the two groups, the local recurrence, distant metastasis and survival in 1 and 3 years, and the occurrence of side effects were compared.【Results】The total effective rate in the two groups was 100%, there was no statistically significant difference between the two groups (P＞0.05); 1-year local recurrence rate showed no significant difference (P＞0.05); 3-years local recurrence rate of the observation group was lower than that of the control group (P＜0.05); 1-year distant metastasis rate of the two groups showed no significant difference
(P＞0.05); 3-year distant metastasis rate of the observation group was lower than that of the control group (P＜0.05); gastrointestinal reaction, liver function, renal function and oral mucosa reaction rate of the two groups had no significant difference (P＞0.05); 1-year survival rate of the two groups had no significant difference (P＞0.05); 3-year survival rate of the observation group was higher than that of the control group (P＜0.05).【Conclusion】Oxaliplatin combined with 5-fluorouracil concurrent intensity-modulated radiotherapy is effective in the treatment of locally advanced nasopharyngeal carcinoma. It can reduce local recurrence and metastasis, and prolong the survival time,which is worthy of clinical application.

Key words： Organoplatinum Compounds/TU Fluorouracil/TU Radiotherapy, Intensity-Modulated Nasopharyngeal Neoplasms/TH

收稿日期: 2017-08-21

PACS:

R739.6

引用本文:

郝洁,齐洪志,杨玉刚,杨建梅,扈向润. 奥沙利铂联合氟尿嘧啶同期调强适形放疗治疗局部晚期鼻咽癌疗效观察[J]. 医学临床研究, 2017, 34(9): 1697-1699,1702.
HAO Jie, QI Hong-zhi, YANG Yu-gang,et al. Clinical Observation of Oxaliplatin Combined with 5-fluorouracil Concurrent Intensity-modulated Radiotherapy in Patients with Locally Advanced Nasopharyngeal Carcinoma. JOURNAL OF CLINICAL RESEARCH, 2017, 34(9): 1697-1699,1702.

链接本文:

http://www.jcr.net.cn/CN/10.3969/j.issn.1671-7171.2017.09.009 或 http://www.jcr.net.cn/CN/Y2017/V34/I9/1697

[1]Xu T.Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study[J].Oral Oncol,2015,51(9):875-879.
[2]Zidan J,Kuten A,Robinson E.Intensive short course chemotherapy followed by radiotherapy of locally advanced nasopharyngeal carcinoma[J].Cancer,2015,77(10):1973-1977.
[3]王娜,王凯,刘雅婷,等.TPF方案对比PF方案诱导化疗后联合同期放化疗治疗局部晚期鼻咽癌的Meta分析[J].兰州大学学报(医学版),2017,43(2):47-54.
[4]Liu ZG.Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis:[J].Oncotarget,2016,7(17):24429-24435.
[5]Mo YL.Sleep characteristics and psychological symptoms in patients with locally advanced nasopharyngeal carcinoma before and after intensity-modulated radiotherapy and concurrent chemotherapy[J].Psychol Health Med,2015,20(6):662-669.
[6]马雄辉,梁彩霞,江丹贤,等.TPF诱导化疗或PF诱导化疗联合同期放化疗治疗局部晚期鼻咽癌的临床观察[J].中国癌症杂志,2016,26(12):1018-1024.
[7]陈建武,张幸平,刘德鑫,等.动脉灌注介入化疗联合同期放化疗治疗局部晚期鼻咽癌的临床疗效及对免疫功能的影响[J].中国老年学,2015,4(13):3629-3631.
[8]Chitapanarux I,Chomprasert K,Nobnaop W,et al.A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer[J].J Radiat Res,2015,56(3):529.
[9]He YX,Wang Y,Cao PF,et al.Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy[J].Cancer,2016,35(12):725-734.
[10]王钇力.TPF、PF方案诱导化疗联合同期放化疗治疗局部晚期鼻咽癌近期疗效比较[J].长江大学学报(自科版),2016,13(6):17-18.
[11]Wang M,Tian H,Li G,et al.Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials[J].Onco targets Ther,2016,7(30):48375-48390.
[12]夏海群,华贻军,彭醒思,等.诱导化疗加放疗与同期放化疗治疗局部晚期鼻咽癌的疗效比较[J].中国肿瘤,2016,25(5):386-390.
[13]Tian R,Ye HX,Zhang BG,et al.Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis[J].Onco targets Ther,2015,8(21):3255-3263.
[14]胡少轩,何小慧,董梅,等.吉西他滨联合异环磷酰胺对铂类方案化疗失败的晚期鼻咽癌患者的疗效及安全性评价[J].中华肿瘤杂志,2015,13(8):632-636.
[15]廖天志.多西他赛联合铂类方案诱导化疗联合同步放化疗治疗局部晚期鼻咽癌的临床观察[J].世界临床医学,2016,10(14):19-21.
[16]周明镇,余元祥,伍方才,等.调强放疗同期联合5-FU+顺铂或奥沙利铂治疗局部晚期鼻咽癌的效果比较[J].广东医学,2017,38(2):308-311.
[17]余海英,曹传华.调强放疗联合多西他赛+奥沙利铂化疗治疗50例鼻咽癌的MRI影像学疗效评估[J].中国CT和MRI杂志,2017,15(1):8-10.
[18]文美玲.GEMOX方案新辅助化疗治疗局部晚期鼻咽癌的临床观察[J].中南医学科学杂志,2013,41(6):596-598.
[19]余元祥,李东升,郭隆佳,等.奥沙利铂联合5-氟尿嘧啶同期调强放疗治疗局部晚期鼻咽癌[J].广东医学,2017,4(11):1740-1742.